{
  "ticker": "SHL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964691",
  "id": "02964691",
  "pages": 6,
  "price_sensitive": false,
  "date": "20250701",
  "time": "1737",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250701/pdf/06lbvk70b94sh4.pdf",
  "summary": "- **Security Issuance Type**: Shares issued as part of an acquisition (non-cash consideration)  \n- **Number of Shares Issued**: 13,833,980 ordinary fully paid shares (SHL)  \n- **Issue Date**: 01/07/2025  \n- **Consideration Value per Share**: **AUD 26.2916** (implied valuation)  \n- **Transaction Context**: Acquisition of LADR-Laboratory Group Dr. Kramer & Colleagues (previously announced via Appendix 3B on 09/12/24)  \n- **Post-Issuance Capital Structure**:  \n  - Total ordinary shares on issue: **494,237,953** (SHL)  \n  - Unquoted securities include options (SHLAM, SHLAK) and performance rights (SHLAZ).  \n\n**No material trading or capital markets action required** (non-dilutive issuance for M&A).",
  "usage": {
    "prompt_tokens": 1422,
    "completion_tokens": 197,
    "total_tokens": 1619,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-01T07:53:41.450935"
}